Prodiem Overnight Relief Therapy
Natural health product licensed in Canada
- Licence holder
- Haleon Canada ULC
- NPN or DIN-HM
- 02246576
- Status
- Inactive licence
- Licence date
- 5 February 2008
- Revision date
- 14 May 2025
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sennoside A&B | 15 mg | Not calculated |
Non-medicinal ingredients
Cellulose - microcrystalline, Poly(alcool vinylique), (p)-hydroxybenzoate de propyle, Shellac, Amidon de maïs modifié, Saccharose, Talc, Dioxyde de titane, Stéarate de magnésium, Oxydes de fer, Phosphate de calcium, dibasique, dihydraté, propylèneglycol, sulfate sodique de lauryle, acacia, Cellulose microcristalline, Parahydroxybenzoate de méthyle, Benzoate de sodium, Dioxyde de silicium, Povidone, Poly(éthylène glycol), Cire de Carnauba, Carbonate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 12 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Relief of occasional constipation
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use daily for more than 1 week without consulting your health care practitioner, as overuse or extended use may cause dependence for bowel function. Ask a health care practitioner before use if -you have kidney disorder or fecal impaction -you are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications, thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. When using this product consult a health care practitioner if symptoms persist or worsen. Stop use and ask a health care practitioner if you experience abdominal pain, cramps, spasms and/or diarrhea. Keep out of reach of children.
- Effets indésirables connus
Stop use and ask a health care practioner if hypersensitivity occurs.
- Contre-indications
Do not use -within 2 hours of other medicines because the desired effect of the other medicine may be reduced. -if you are pregnant or breasfeeding - the presence of abdominal pain, nausea, fever or vomiting -if you have abdominal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn’s disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhea.
Source
Official Health Canada record, licence 02246576
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.